LIQUIDIA CORP
LQDANASDAQ🏆 #1414 by market capEarnings Nov 10 · PreUS Equity
$45.04▼ $0.70 (−1.53%)
Latest quoteTrack LQDA
Get earnings, price moves & breaking news on Telegram
24h▼ 1.5%
7d▲ 13.6%
14d▲ 29.7%
30d▼ 36.3%
ytd▲ 30.5%
1y▲ 100.9%
🏦Market Cap
$4.03B
Small Cap
📈Revenue Growth (YoY)
2233.7%
High Growth
📊Gross Margin
92.6%
High
💵FCF Margin
—
⚖️P/S Ratio
9.0x
Elevated
Otter Score
60
Fair
Trading Snapshot
- Day Range
- $44.46 – $47.04
- 52-Week Range
- $22.05 – $93.61
- Volume (shares)
- 109,388
- Avg Volume (shares)
- —
- Shares Outstanding
- 89.5M
- Next Earnings
- 2026-11-10
Fundamentals Snapshot
- Annual Revenue
- $158M
- Last Q Revenue
- $172M
- P/E Ratio
- 29.3
- P/S Ratio
- 9.0x
- EPS (TTM)
- $1.39
- Dividend Yield
- —
- Dilution (1yr)
- +18.1%
LIQUIDIA CORP
LQDAFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$158M▲ +1031.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
91.6%▲ +58.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$51M▼ −57.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$40M▼ −59.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
100.1M▲ +18.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$7M▼ −$61M YoY
StockOtter · stockotter.spaceAbout LIQUIDIA CORP
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
60/100
Analyst Ratings
ⓘConsensus
Buy
15 analysts
Strong Buy5
Buy6
Hold4
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.